The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | D | Dermatologicals | |
2 | D10 | Anti-acne preparations | |
3 | D10A | Anti-acne preparations for topical use | |
4 | D10AX | Other anti-acne preparations for topical use |
Code | Title | |
---|---|---|
D10AX01 | Aluminium chloride | |
D10AX02 | Resorcinol | |
D10AX03 | Azelaic acid | |
D10AX04 | Aluminium oxide | |
D10AX05 | ||
D10AX06 | ||
D10AX30 | Various combinations |
Active Ingredient | Description | |
---|---|---|
Aluminium chloride |
Aluminium chloride hexahydrate acts locally, in the stratum comeum and in the terminal duct, to relieve hyperhidrosis. It is is acidic and is thought to act by diffusing into the sweat ducts where on neutralisation it forms gelatinous hydroxides which obstruct the flow of sweat. |
|
Azelaic acid |
Azelaic Acid is a naturally occurring dicarboxylic acid. Azelaic acid possesses antibacterial, keratolytic, comedolytic, and anti-oxidant activity. Azelaic acid is bactericidal against Proprionibacterium acnes and Staphylococcus epidermidis due to its inhibitory effect on the synthesis of microbial cellular proteins. |
Title | Information Source | Document Type | |
---|---|---|---|
ACZONE Gel | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
ANHYDROL FORTE Cutaneous solution | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
DICLOR Solution for topical application | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
FINACEA Gel | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
NICAM Gel | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
SKINOREN Cream | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |